January 1, 1970 · FLEMING | NOLEN | JEZ, L.L.P.
The National Joint Registry for England and Wales has reported that all metal hips, like DePuy’s ASR, have a higher failure rate than traditional hip replacements.
This is data similar to the data that triggered the recall of DePuy Orthopedics, a Johnson & Johnson company, ASR XL Acetabular Hip System. In fact, the new data shows a significant increase in ASR hip implant failure then originally discussed. The UK Registry’s data supports that the ASR hip failed in approximately 1/3 of patients.
This report coincides with the FDA’s order to DePuy and other hip implant manufacturers to conduct further studies on metal-on-metal hip implants. Specifically, the FDA wants the manufacturer’s of metal-on-metal hips to study the rate of failure of the metal-on-metal hips and the impact on the patients. The FDA’s call for more studies was sparked by the thousands of complaints it received regarding metal-on-metal hip implants, like DePuy’s ASR hip.
Patients with metal-on-metal hip implants, like DePuy’s ASR, complain of the following:
- Pain and Swelling
- Elevated Cobalt and Chromium Levels
- Clicking & Popping
- Loosening of the Implant
- Need for Revision Surgery
Based on the data from the UK, it is likely that the number of complaints to the FDA will increase and we will begin to see more data surface about the metal-on metal hip implant failure rates.